Details

Aim : Retrospective analysis of 174 blood samples sent to the CHUV for vedolizumab trough levels. Clinical data have been extracted from the SIBDCS database, and from patient files. Data have been analyzed and presented at ECCO. The study is now completed and its manuscript ready to be submitted shortly.

Contact: mmaillard@gesb.ch